This inventor holds 21 USPTO granted patents, plus 4 CIPO patents and 8 EPO patents, primarily in Photodynamic Therapy. Top assignees: Biolitec Pharma Marketing Ltd, Ceramoptec Industries, Inc., Biolitec Unternehmensbeteiligungs Ii Ag. Active years: 2004-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lingenfeld, DE (2010 - 2012)
- Jena, DE (2004 - 2015)
- Bergholz Rehbrücke, DE (2015)
- Bergholz-Rehbruecke, DE (2016)
- Nuthetal, DE (2015 - 2020)
Company Filing History:
12 out of 39 
4 out of 91 
3 out of 17 
Years Active: 2004-2020
Areas of Expertise:
Title: Volker Albrecht: A Pioneer in Biologically Active Compounds and Photodynamic Therapy
Introduction:
Volker Albrecht, an esteemed inventor and researcher based in Jena, Germany, has made significant contributions to the field of biotechnology and pharmaceuticals. With 19 patents to his name, Albrecht's innovative work primarily focuses on the development and application of metal complexes in anti-tumor and anti-bacterial therapy, as well as the conjugation of porphyrinoid photosensitizers for photodynamic therapy. This article delves into Albrecht's latest patents, career highlights, notable collaborations, and his pioneering role in advancing therapeutic applications.
Latest Patents:
Albrecht's latest patents revolve around the use of biologically active compounds as photosensitizers for diagnostic and therapeutic purposes. In one patent, he explores the application of metal complexes as photosensitizers for photodynamic therapy (PDT) in the treatment of cancer, infections, and other hyperproliferative diseases. These compounds exhibit toxicity against tumor cells, bacteria, inflammation-related cells, and can be utilized for light-independent treatments as well.
Another significant patent by Albrecht is the development of conjugates of porphyrinoid photosensitizers and glycerol-based polymers for photodynamic therapy. This approach enables the targeted delivery of photosensitizers to desired sites, ensuring enhanced efficacy in PDT while minimizing undesired effects such as solubility problems or delayed pharmacokinetics.
Career Highlights:
Throughout his illustrious career, Albrecht has made substantial contributions to the field of pharmaceutical research. He has been associated with renowned companies like Biolitec Pharma Marketing Ltd and Ceram Optec Industries Inc. Albrecht's expertise in synthesizing metal or half-metal complex structures and incorporating substituted 2,3,5,6-tetrafluorophenyl-dipyrromethene (2,3,5,6-tetrafluorophenyldipyrrin) units has been instrumental in advancing the field of biologically active compounds.
Collaborations:
Albrecht's work has benefited from the collaboration and expertise of his coworkers. In particular, Arno Wiehe and Susanna Gräfe have played pivotal roles in his research endeavors. Their collective efforts have furthered the understanding of photodynamic therapy and contributed to the development of novel therapeutic applications.
Conclusion:
Volker Albrecht's dedication and scientific expertise in the field of biologically active compounds and photodynamic therapy have paved the way for innovative diagnostic and therapeutic approaches. His patented inventions demonstrate promising possibilities in combating cancer, infections, inflammatory diseases, and various other medical conditions. Albrecht continues to be a driving force in the advancement of pharmaceutical research, leaving a lasting impact on the field and offering hope for improved treatment options in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile